MIBG Therapy for Pheochromocytomas and Paragangliomas

2 Views
administrator
administrator
07/02/23

Dr. David Mankoff discusses meta-Iodobenzylguanidine (MIBG) therapy, which is a highly targeted therapy for treatment of pheochromocytomas and paragangliomas, at the 2012 Focus on Neuroendocrine Tumors Conference.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next